Little could be done for children with Dushin muscular dystrophy until the gene

responsible for the disease was known. Hear about the possibilities geneticists are now exploring on the latest episode of

targeting the toughest diseases, a new podcast by Bloomberg Media Studios and Vertex Pharmaceuticals. Welcome to Crash Course, a podcast about business, political and social disruption, and what we can learn from it.

I'm Tim O'Brien. Every week on Crash Course I'm going to bring listeners directly into

the arenas where epic upheavals occur and I'm going to explore the lessons we can learn when creativity and ambition collide with competition and power.

Listen to Crash Course every Tuesday on the I Heart Radio app, Apple Podcasts, or wherever you get your

podcasts. Welcome to the Bloomberg surveillance podcast. I'm Tom Keene.

Daily, we bring you insight from the best in economics, finance, investment, and international relations,

find Bloomberg surveillance on Apple Podcasts, SoundCloud, Bloomberg.com, and of course, on the Bloomer.

Here in New York joining us, I'm pleased to say is Kay Moore,

Blackrock Investment Institute, Chief Equity Strategist.

Good morning to you, Kate.

What should we be looking for a little bit later from Chairman Pound and Co?

So I think the equity market and kind of risk assets in general have become pretty

comfortable and complacent with the idea that monetary policy is going to stay

accommodative forever and ever and ever. So I think the biggest thing to watch is

going to be for equity markets the dot plot.

I think for kind of broader markets and fixed income we're going to be focused a lot on the balance sheet and

reinvestment and the composition the Treasury composition which is a little bit more technical.

But in general, equity investors,

and I would say risk asset investors broadly,

want to see that monetary policy is not going to move much or slash at all in the

...